Catalio Capital Management, LP

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
47
Total value ($000)
$538,308
Net value change ($000)
+6,206 (1.2%)
New positions
14
Sold out positions
6
Turnover %
40.2%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ARWR 20,633 NEW
CELC 18,338 NEW
GH 16,512 NEW
TXG 14,822 NEW
AMLX 14,721 NEW
Ascendis Pharma AS 14,641 172.8%
ENTXW 11,412 NEW
BMRN 8,698 NEW
ANNX 8,404 NEW
RYTM 8,152 NEW
Top Reduces (Value $000, Stocks/ETFs)
GILD -34,024 -100.0%
INCY -21,723 -100.0%
NTRA -17,129 -76.8%
HTFL -13,377 -78.2%
AXSM -10,570 -100.0%
JNJ -8,947 -25.4%
KPTI -8,001 -87.0%
DFTX -7,515 -28.4%
SNDX -7,333 -27.6%
AVALYN PHARMACEUTICALS INC -6,768 -12.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type